NURO — NeuroMetrix Income Statement
0.000.00%
Last trade - 00:00- $8.94m
- -$4.16m
- $3.03m
- 20
- 42
- 82
- 46
Annual income statement for NeuroMetrix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 7.38 | 8.25 | 8.26 | 5.9 | 3.03 |
| Cost of Revenue | |||||
| Gross Profit | 5.25 | 5.92 | 5.75 | 3.95 | 1.68 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 9.47 | 10.5 | 13 | 13.1 | 11.8 |
| Operating Profit | -2.09 | -2.28 | -4.74 | -7.15 | -8.78 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.09 | -2.28 | -4.42 | -6.53 | -7.81 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.09 | -2.28 | -4.42 | -6.53 | -7.81 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.09 | -2.28 | -4.42 | -6.53 | -7.81 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.09 | -2.28 | -4.42 | -6.53 | -7.81 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -4.62 | -3.37 | -4.96 | -6.27 | -3.96 |